





Antiplatelets After PCI in 2017, Which Agents and for how Long? - Pablo Avanzas
Summary
Antiplatelets After PCI in 2017, Which Agents and for how Long? - Presented by Pablo Avanzas at ISCP 2017.
Simple Education, is a leading provider of coronary physiology and intracoronary imaging courses to aid treatment of complex coronary artery disease.
Speakers
Works at Hospital Central Asturias, Oviedo, Spain. Features in 1 video on Wondr Medical. Pablo... Works at Hospital Central Asturias, Oviedo, Spain. Features in 1 video on Wondr Medical. Pablo Avanzas generally speaks on Aorta, Coronary arteries, PCSK9 Antagonists, and Anti-Platelet Drugs .
Join the conversation
Related videos

Novel Lipid Lowering Therapy Against Coronary atherosclerosis: Role of PCSK9 Inhibitors - Masayuki Yoshida

Discussion of ISCP 2017 - Coronary Artery Disease - Joint Session ISCP and European Association of Professors Emeriti
